Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract

Dr Claudia Allemani’s background covers the range from applied mathematics to public health and education, via epidemiology and medical statistics. She graduated in mathematics from the University of Turin (Italy) in 1996, then completed a Masters in Statistical and Informatic Methods for data analysis in the University of Milan (Italy) in 1998, followed by a specializzazione [PhD equivalent] in Medical Statistics in 2001 and a PhD in Public Health and Education in 2006, both in the University of Pavia (Italy). She was elected a Fellow of the Higher Education Academy in July 2012. She became an Honorary Member of the UK Faculty of Public Health (UKFPH) in March 2014. She was awarded the inaugural Global Public Health Award from the UKFPH in June 2016. She obtained a European Research Council Consolidator grant in November 2017 to carry out a world-wide study on inequalities in survival from cancers of the breast, cervix and ovary.


Claudia was a Research Fellow in Medical Statistics and Epidemiology in Pavia (Italy) from 1998 to 2001. From 2001 to 2011, she worked as a Research Fellow in the Epidemiology Unit, Istituto Nazionale Tumori, Milan (Italy), on EUROCARE (European Cancer Registry-based study of survival and care of cancer patients) and related studies, and on the HAEMACARE project (haematological malignancies). She has been working in the Cancer Survival Group at LSHTM since October 2011.


Claudia’s main interests are in international comparisons of cancer survival, “high-resolution” studies and the estimation of avoidable premature deaths, with a focus on their impact on cancer policy. She has more than 15 years’ experience in this domain. She leads a team of five researchers on data management, quality control and survival analysis for the global surveillance of cancer survival (CONCORD), for which she is co-Principal Investigator.


She has been a member of the European Network of Cancer Registries Advisory Committee, working with the European Union’s Joint Research Centre in Ispra (Italy), to produce a set of standardised data quality control procedures for European cancer registries. She has been an advisor to the Italian Ministry of Health on the EU programme for European guidelines on cancer control (CanCon). She has taught epidemiology and medical statistics in many countries.

Forthcoming events

Genomics and the individual response to infection and vaccination

Monday, 07 October 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar room

Immune reconstitution inflammatory syndrome in people with HIV: causes and consequences

Monday, 04 November 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar room

mRNA vaccines and paediatric RSV

Monday, 11 November 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar room

Fake vaccines: The problem - and finding solutions

Monday, 18 November 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

The potential of vaccination to prevent congenital CMV

Monday, 25 November 2024, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms